Pharmaceutical Care in VA Nursing Home

Focus on the Elderly in a Nursing Home Clinical Trial

Official title:

The Impacts of Pharmaceutical Cares on the Elderly in a VA Nursing Home.

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01823757
• Other study ID #: VGHTCPHARMACY1
• Secondary ID: TCVGHPHARM_RESEA
• Status: Active, not recruiting
• Phase: N/A
• First received: March 29, 2013
• Last updated: August 27, 2014
• Start date: April 2013
• Est. completion date: December 2015

Study information

• Verified date: August 2014
• Source: Taichung Veterans General Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

This study investigates the effect of pharmaceutical care on a Veteran nursing home. 100 patients will be selected into this controlled study.The hypothesis are:

1. After patients receive pharmaceutical care, their drug related problems will be decreased.

2. After patients received pharmaceutical care, their self-reported medical expenditure will be decreased.

Description:

Around 200 residents in a Veteran nursing home will be selected for reviewing inclusion and exclusion criteria. A total of 100 subjected are selected into this randomized controlled trial. Each group will have 50 subjects and then divides into 4 subgroup, according to their drug items used (5-7 and over 8 items used).

The inclusion criteria:

1. Residents of the Veteran nursing home.

2. over 65 years old.

3. complete comprehensive geriatric assessment (CGA)

4. prescription drugs more than 4 times/day, excluding stat order.

5. with 2 or more chronic diseases.

Exclusion criteria:

1. residents who were in the pharmaceutical care project of Taiwan Pharmacists Association.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 100
• Est. completion date: December 2015
• Est. primary completion date: July 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Residents in the Veteran nursing home

• Age over 65 years old

• Complete Comprehensive Geriatric Assessment (CGA)

• Use more than 4 drug item per day (excluding stat order)

• subjects with more than 2 chronic diseases.

Exclusion Criteria:

• subjects who were in pharmaceutical care project of Taiwan Pharmacist Association.

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Focus on the Elderly in a Nursing Home

Intervention

Other:
• Pharmaceutical care
pharmacists provide pharmaceutical care to the intervention group, comparing to ordinary care in control group

Locations

Country	Name	City	State
Taiwan	Changhua Domiciliar Center	Changhua City

Sponsors (1)

Lead Sponsor	Collaborator
Taichung Veterans General Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	quality of life measure	use health outcome measure, EQ-5D, to assess the quality of life issue.	one year	No
Primary	potential inappropriate medication (PIA)		one year	No
Secondary	drug items used	the controlled group is expected to have less drug items used.	one year	No
Secondary	medical expenditure	subjects self-reported outpatients visit, hospitalization, drug, and healthy supplemental used.	one year	No